POLR1B
DNA-directed RNA polymerase I subunit RPA2
Also known as: FLJ10816, FLJ21921, RPA135, RPA2, RPA2_HUMAN, Rpo1-2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H9Y6
- Gene
- POLR1B
- Ensembl
- ENSG00000125630
- Chromosome
- 2
- Canonical length
- 1135 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins
- Subcellular location
- Nucleoli fibrillar center,Cytosol
OverviewNCBI Gene
Eukaryotic RNA polymerase I (pol I) is responsible for the transcription of ribosomal RNA (rRNA) genes and production of rRNA, the primary component of ribosomes. Pol I is a multisubunit enzyme composed of 6 to 14 polypeptides, depending on the species. Most of the mass of the pol I complex derives from the 2 largest subunits, Rpa1 and Rpa2 in yeast. POLR1B is homologous to Rpa2 (Seither and Grummt, 1996 [PubMed 8921381]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
1135 residues, UniProt reviewed canonical sequence.
>Q9H9Y6|POLR1B
1 MDPGSRWRNL PSGPSLKHLT DPSYGIPREQ QKAALQELTR AHVESFNYAV HEGLGLAVQA
61 IPPFEFAFKD ERISFTILDA VISPPTVPKG TICKEANVYP AECRGRRSTY RGKLTADINW
121 AVNGISKGII KQFLGYVPIM VKSKLCNLRN LPPQALIEHH EEAEEMGGYF IINGIEKVIR
181 MLIMPRRNFP IAMIRPKWKT RGPGYTQYGV SMHCVREEHS AVNMNLHYLE NGTVMLNFIY
241 RKELFFLPLG FALKALVSFS DYQIFQELIK GKEDDSFLRN SVSQMLRIVM EEGCSTQKQV
301 LNYLGECFRV KLNVPDWYPN EQAAEFLFNQ CICIHLKSNT EKFYMLCLMT RKLFALAKGE
361 CMEDNPDSLV NQEVLTPGQL FLMFLKEKLE GWLVSIKIAF DKKAQKTSVS MNTDNLMRIF
421 TMGIDLTKPF EYLFATGNLR SKTGLGLLQD SGLCVVADKL NFIRYLSHFR CVHRGADFAK
481 MRTTTVRRLL PESWGFLCPV HTPDGEPCGL MNHLTAVCEV VTQFVYTASI PALLCNLGVT
541 PIDGAPHRSY SECYPVLLDG VMVGWVDKDL APGIADSLRH FKVLREKRIP PWMEVVLIPM
601 TGKPSLYPGL FLFTTPCRLV RPVQNLALGK EELIGTMEQI FMNVAIFEDE VFAGVTTHQE
661 LFPHSLLSVI ANFIPFSDHN QSPRNMYQCQ MGKQTMGFPL LTYQDRSDNK LYRLQTPQSP
721 LVRPSMYDYY DMDNYPIGTN AIVAVISYTG YDMEDAMIVN KASWERGFAH GSVYKSEFID
781 LSEKIKQGDS SLVFGIKPGD PRVLQKLDDD GLPFIGAKLQ YGDPYYSYLN LNTGESFVMY
841 YKSKENCVVD NIKVCSNDTG SGKFKCVCIT MRVPRNPTIG DKFASRHGQK GILSRLWPAE
901 DMPFTESGMV PDILFNPHGF PSRMTIGMLI ESMAGKSAAL HGLCHDATPF IFSEENSALE
961 YFGEMLKAAG YNFYGTERLY SGISGLELEA DIFIGVVYYQ RLRHMVSDKF QVRTTGARDR
1021 VTNQPIGGRN VQGGIRFGEM ERDALLAHGT SFLLHDRLFN CSDRSVAHVC VKCGSLLSPL
1081 LEKPPPSWSA MRNRKYNCTL CSRSDTIDTV SVPYVFRYFV AELAAMNIKV KLDVVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against POLR1B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 11 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 11 nTPM
- tonsil: 10 nTPM
- liver: 10 nTPM
- thyroid gland: 9.9 nTPM
- lymph node: 8.7 nTPM
- testis: 7.9 nTPM
Single-cell type
- early spermatids: 193 nCPM
- late primary spermatocytes: 132 nCPM
- late spermatids: 41 nCPM
- erythrocyte progenitors: 39 nCPM
- megakaryocyte progenitors: 37 nCPM
- megakaryocyte-erythroid progenitors: 34 nCPM
Immune cell
- MAIT T-cell: 22 nTPM
- NK-cell: 15 nTPM
- T-reg: 15 nTPM
- myeloid DC: 14 nTPM
- naive CD8 T-cell: 13 nTPM
- naive CD4 T-cell: 12 nTPM
Brain region
- choroid plexus: 11 nTPM
- hypothalamus: 9.9 nTPM
- cerebellum: 9.5 nTPM
- cerebral cortex: 9.2 nTPM
- white matter: 9.1 nTPM
- basal ganglia: 8.7 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about POLR1B.
Disease | AllUniProt
Conditions POLR1B is implicated in, by any mechanism.
- Treacher Collins syndrome 4 (TCS4) MIM:618939
Disease | GeneticClinVar
5 pathogenic / likely-pathogenic of 185 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Treacher Collins syndrome 4
- Treacher Collins syndrome
- POLR1B-related disorder
Disease | ImmuneIEDB
Conditions an epitope on POLR1B was assayed in.
- melanoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.25
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.97
- DepMap mean gene effect
- -1.49
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA binding
- DNA-directed RNA polymerase activity
- DNA/RNA hybrid binding
- ribonucleoside binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- DNA-directed RNA polymerase, subunit 2, hybrid-binding domain
- RNA polymerase, beta subunit, conserved site
- RNA polymerase Rpb2, domain 7
- RNA polymerase Rpb2, domain 2
- RNA polymerase, beta subunit, protrusion
- RNA polymerase Rpb2, domain 3
- RNA polymerase Rpb2, OB-fold
- DNA-directed RNA polymerase, subunit 2
- DNA-directed RNA polymerase, subunit 2, hybrid-binding domain superfamily
- RNA polymerase Rpb2, domain 2 superfamily
- RNA polymerase Rpb2, domain 6
- RNA polymerase Rpb2, domain 7
- RNA polymerase Rpb2, domain 2
- RNA polymerase beta subunit
- RNA polymerase Rpb2, domain 3
- DNA-directed RNA polymerase I subunit RPA2, domain 4
- RNA polymerase I, Rpa2 specific domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of POLR1B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads POLR1B as an antibody target. Whether an autoantibody or antibody against POLR1B could matter depends on whether native POLR1B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
POLR1B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label POLR1B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...